The future of haemagglutinin stalk-based universal influenza vaccines
| Errataetall: |
CommentOn: Lancet Infect Dis. 2022 Jul;22(7):1062-1075. - PMID 35461522 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
The Lancet. Infectious diseases - 22(2022), 7 vom: 24. Juli, Seite 926-928 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Isakova-Sivak, Irina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 28.06.2022 Date Revised 07.07.2022 published: Print-Electronic CommentOn: Lancet Infect Dis. 2022 Jul;22(7):1062-1075. - PMID 35461522 Citation Status MEDLINE |
|---|
| doi: |
10.1016/S1473-3099(22)00056-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33990643X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33990643X | ||
| 003 | DE-627 | ||
| 005 | 20231226003934.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1473-3099(22)00056-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1132.xml |
| 035 | |a (DE-627)NLM33990643X | ||
| 035 | |a (NLM)35461523 | ||
| 035 | |a (PII)S1473-3099(22)00056-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Isakova-Sivak, Irina |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The future of haemagglutinin stalk-based universal influenza vaccines |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.06.2022 | ||
| 500 | |a Date Revised 07.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Lancet Infect Dis. 2022 Jul;22(7):1062-1075. - PMID 35461522 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a Hemagglutinin Glycoproteins, Influenza Virus |2 NLM | |
| 650 | 7 | |a Hemagglutinins |2 NLM | |
| 650 | 7 | |a Influenza Vaccines |2 NLM | |
| 700 | 1 | |a Rudenko, Larisa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Infectious diseases |d 2001 |g 22(2022), 7 vom: 24. Juli, Seite 926-928 |w (DE-627)NLM117564362 |x 1474-4457 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:7 |g day:24 |g month:07 |g pages:926-928 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1473-3099(22)00056-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 7 |b 24 |c 07 |h 926-928 | ||